<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031000</url>
  </required_header>
  <id_info>
    <org_study_id>IDK_ISO_2021_002</org_study_id>
    <nct_id>NCT05031000</nct_id>
  </id_info>
  <brief_title>Blood Glucose Monitoring Systems: Discounter Versus Brand</brief_title>
  <official_title>Cheap Equals Bad? Comparative System Accuracy of POCT Blood Glucose Monitoring Systems Under the Aspect of Aspect of Pricing: Discounter Versus Brand</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut fur Diabetes Karlsburg GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut fur Diabetes Karlsburg GmbH</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study assesses the system accuracy of 5 blood glucose monitoring systems pursuant to ISO&#xD;
      15197 under the aspect of the system's prospected costs for the user.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2021</start_date>
  <completion_date type="Actual">October 6, 2021</completion_date>
  <primary_completion_date type="Actual">October 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of system accuracy based on DIN EN ISO 15197</measure>
    <time_frame>day 1</time_frame>
    <description>Assessment of the analytical measurement performance of 5 blood glucose montoring systems based on procedures defined in DIN EN ISO 15197</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Subject POCT glucometer measurement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood glucose measurement POCT glucometer</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood glucose measurement: POCT</intervention_name>
    <description>measurement of blood glucose concentration using 5 different POCT glucometer</description>
    <arm_group_label>Subject POCT glucometer measurement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood glucose measurement: reference</intervention_name>
    <description>measurement of blood glucose concentration using 2 different laboratory analyzer</description>
    <arm_group_label>Subject POCT glucometer measurement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, with clinical indication for blood glucose measurement&#xD;
&#xD;
          -  Signed informed consent form&#xD;
&#xD;
          -  Minimum age of 18 years&#xD;
&#xD;
          -  Subjects are legally competent and capable to understand character, meaning and&#xD;
             consequences of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or lactation period&#xD;
&#xD;
          -  Severe acute disease (at the study physician's discretion)&#xD;
&#xD;
          -  Severe chronic disease with inherent risk of aggravation by the procedure (at the&#xD;
             study physician's discretion)&#xD;
&#xD;
          -  Current constitution that compromises the subject's capability to participate in the&#xD;
             study (at the study physician's discretion)&#xD;
&#xD;
          -  A current constitution that does not allow participating in the study (e.g. hematocrit&#xD;
             out of BGM specifications, medication known to influence blood glucose measurements;&#xD;
             see Appendix A of ISO 15197)&#xD;
&#xD;
          -  Being unable to give informed consent&#xD;
&#xD;
          -  &lt; 18 years&#xD;
&#xD;
          -  Legally incompetent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eckhard Salzsieder, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut fur Diabetes Karlsburg GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut f√ºr Diabetes Karlsburg GmbH</name>
      <address>
        <city>Karlsburg</city>
        <state>Mecklenburg Vorpommern</state>
        <zip>17495</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://medlineplus.gov/bloodsugar.html</url>
    <description>Blood sugar</description>
  </link>
  <link>
    <url>https://www.iso.org/standard/54976.html</url>
    <description>ISO 15197</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

